NADA, Elisabetta

NADA, Elisabetta  

SCIENZE CHIRURGICHE  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
Hepatic fibrosis of any origin in a large population of type 2 diabetes patients 2021 Giorda CB, Picariello R, Tartaglino B, Nada E, Linzalata C, Romeo F, Costa G, Gnavi R
Metabolic Syndrome after liver transplantation: have risk factors changed over time? 2015 Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E.
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant 2014 F. Tandoi; E. Nada; F. Pittaluga; F. Fop; F. Lupo; R. Romagnoli; M. Salizzoni
ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION 2015 Lupo, Francesco; Tandoi, Francesco; Mazza, Elena; Catalano, Giorgia; Nada, Elisabetta; Patrono, Damiano; Galasso, Erica; Mirabella, Stefano; Cocchis, Donatella; Romagnoli, Renato; Salizzoni, Mauro
Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in De-Novo Liver Transplantation 2015 Lupo, Francesco; Tandoi, Francesco; Patrono, Damiano; Mazza, Elena; Catalano, Giorgia; Nada, Elisabetta; Galasso, Erica; Romagnoli, Renato; Salizzoni, Mauro
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection 2012 F.Tandoi; R.Romagnoli; S.Martini; E.Mazza; E.Nada; D.Cocchis; F.Lupo; M.Salizzoni
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 2012 F.Tandoi; R.Romagnoli; S.Martini; E.Mazza; E.Nada; D.Cocchis; F.Lupo; M.Salizzoni
RELATIONSHIP BETWEEN LIVER GRAFT STEATOSIS, VIRAL RECURRENCE AND POST-LIVER TRANSPLANTATION SURVIVAL IN HEPATITIS C VIRUS POSITIVE RECIPIENTS 2013 Nada, Elisabetta; Mirabella, Stefano; Tandoi, Francesco; Romagnoli, Renato; David, Ezio; Lupo, Francesco; Patrono, Damiano; Salizzoni, Mauro
Risk factors for arterial hypertension after liver transplantation 2018 Di Stefano, Cristina*; Vanni, Ester; Mirabella, Stefano; Younes, Ramy; Boano, Valentina; Mosso, Elena; Nada, Elisabetta; Milazzo, Valeria; Maule, Simona; Romagnoli, Renato; Salizzoni, Mauro; Veglio, Franco; Milan, Alberto
Risk factors for metabolic syndrome after liver transplantation: what has changed over time 2015 Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Mezzabotta, L.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E.
USE OF GRAFTS FROM HEPATITIS C VIRUS POSITIVE DONORS IN LIVER TRANSPLANTATION: OUTCOMES UNDER CURRENT SELECTION CRITERIA 2013 Tandoi, Francesco; Romagnoli, Renato; Lupo, Francesco; Nada, Elisabetta; Patrono, Damiano; Mirabella, Stefano; Salizzoni, Mauro
Vascular Remodeling of Visceral Arteries Following Interruption of the Splenic Artery During Liver Transplantation 2019 Patrono D.; Franchi E.; Guarasci F.; Bartoli G.; Nada E.; Rigo F.; Ottobrelli A.; Fonio P.; Salizzoni M.; Romagnoli R.